Pre-ASCO中国临床肿瘤峰会由美中抗癌协会(USCACA)和世易医健(eChinaHealth)主办,百济神州(BeiGene)合办。全新上线的网络会议将为您涉猎更广更热门的议题并邀请更多嘉宾。

第三期网络会议主题为“肿瘤临床试验联盟在全球肿瘤新药研发中的贡献”。临床试验中心和临床试验联盟在推进新型抗癌治疗和规范治疗方案方面发挥了重要作用。它们提供了广泛的患者群体,并能够按照共享的质量标准进行操作。我们分别邀请了中国胸部肿瘤研究协作组专家吴一龙教授和美国西南肿瘤协作组专家Karen Kelly教授,以及跨国企业肿瘤研发专家主管。他们将分享对临床试验联盟成功的见解以及对全球合作的想法。

 

主办方

                                        

合办方

                                                         

时 间

 

5月23日周六(中国北京时间) 上午9点

5月22日周五(美国东部时间) 晚上9点

5月22日周五(美国西部时间) 晚上6点

 

报 名 注 册

 

会议开放免费注册,请扫描下方二维码报名

■ 我们将于会议前以邮件形式发送给您参会邀请。

■ 如您已报名第一、二期,我们将为您自动注册第三期,您无需重复注册。


                                                                    ASCO中国会议微信群

每期网络会议结束,我们将在微信群内发布该场会议视频及后续精彩会议!不想错过更多ASCO中国会议精华演讲?就请加入我们!(四大群同步更新,老朋友不必重复加入)

                                                                                     

                                                     请扫描二维码加入,或添加会议经理入群!

                                                                                    预   告

                                                                 ASCO Direct™ China 网络会议

最权威 01

2020 ASCO Direct™ China网络会议ASCO官方授权世易医健在大中华区独家举办,汇总2020年ASCO在该领域内最新、最具亮点的演讲。

最全面 02

2020 ASCO Direct™ China网络会议将由我们的专家委员会选取2020年美国临床肿瘤学会年会 (ASCO Annual Meeting) 与ASCO胃肠道癌症专题会议(ASCO Gastrointestinal Cancers)、ASCO 泌尿生殖系统癌症专题会议(ASCO Genitourinary Cancers Symposium)和ASCO-SITC临床免疫肿瘤学专题会议(ASCO-SITC Clinical Immuno-Oncology Symposium)精华内容,按照系列主题,视频动态再现肿瘤领域最新研究与进程的精彩演讲!

最独特 03

2020 ASCO Direct™ China网络会议将采用专题精华演讲+中美专家圆桌讨论形式,使您全方位理解会议内容!

 

全新上线的网络会议为您涉猎更权威更热门的议题并邀请嘉宾参与交流,“ASCO中国会议微信群”欢迎您的加入!

美中抗癌协会

US Chinese Anti-Cancer Association

U.S. Chinese Anti-Cancer Association (USCACA) is a non-profit professional organization founded in 2009. With members from academia, industry and government, USCACA facilitates collaboration among cancer research and physicians in the United States and China. Our current focus is on expediting novel cancer drug development by fostering clinical trial networks, sharing best practices and knowledge of clinical trial, and providing education and training opportunities. USCACA collaborates with Chinese Anti-Cancer Association, Chinese Society for Clinical Oncology, and other professional associations. Our mandate is to improve cancer treatment through research, education, and collaboration.

世易医健

eChinaHealth

eChinaHealth is an integrated media for China healthcare and pharmaceutical segments. eChinaHealth services include digital platform and media, conferences and events, data and consulting, and social network and community.

eChinaHealth is exclusive China sale representation for ASCO Publications including “Journal of Clinical Oncology”, “Journal of Clinical Practice”, and “ASCO Post”, etc. eChinaHealth and ASCO plan to organize a series of ASCO Direct™ conference in China. The ASCO Direct™ program is an educational initiative that condenses highlights from ASCO Meeting into a 1-day China program, in an effort to provide Chinese doctors’ access to the most cutting-edge research discussed at ASCO meetings.

百济神州

BeiGene

BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. Our mission is to become a global leader in the discovery, development, and commercialization of innovative, molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.